Regression of sclerodermatous skin lesions in a patient with carcinoid syndrome treated by octreotide.
Pavlovic
M
M
Saiag
P
P
Lotz
J P
JP
Marinho
E
E
Clerici
T
T
Izrael
V
V
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008303:Malignant Carcinoid Syndrome / Q000150:complications* / Q000188:drug therapy; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use*; D012075:Remission, Spontaneous; D012594:Scleroderma, Localized / Q000209:etiology*
D018931:Antineoplastic Agents, Hormonal; D015282:Octreotide